This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Ronald C. Gentile, MD; John M. Lewis, MD; James E. Puklin, MD
Detroit, Mich

Arch Ophthalmol. 1997;115(9):1204-1205.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Intravitreal ganciclovir implantation is an effective treatment for cytomegalovirus retinitis. An implant recently has been approved by the Food and Drug Administration and is commercially available. Because implantation eliminates the need for an indwelling catheter and offers an improved quality of life, it may become a more popular initial treatment for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.

As with all intraocular procedures, complications can occur. We report one case in which the placement of an intravitreal ganciclovir implant was complicated by the formation of cyclodialysis. This necessitated the repositioning of the implant to a different quadrant. Despite gonioscopic evidence of the cyclodialysis cleft, the eye remained normotensive postoperatively.

Report of a Case.

A 45-year-old phakic man with acquired immunodeficiency syndrome and bilateral cytomegalovirus retinitis elected to undergo insertion of an intravitreal ganciclovir implant in his right eye. He had previously undergone uncomplicated placement of an intravitreal . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?